Jan 21 (Reuters) - Merck & Co unit MSD and the Coalition for Epidemic Preparedness Innovations said on Wednesday they have ...
“Through this CEPI-supported partnership, SK bioscience will continue to play a critical role in improving Zaire ebolavirus ...
allAfrica.com on MSN
New $30 Million Push to Make Ebola Vaccines More Affordable and Easier to Store for Low - and Middle-Income Countries
A major breakthrough in the fight against Zaire ebolavirus was announced at the World Economic Forum in Davos. CEPI (the Coalition for Epidemic Preparedness Innovations) is partnering with the ...
With $30 million in funding from the Coalition for Epidemic Preparedness Innovations (CEPI), Merck & Co. | The project, which involves Merck, SK Biosciences, Hilleman Laboratories and CDMO IDT ...
Merck & Co., Inc. (NYSE:MRK) is included among Dividend Contenders List: Top 20 Stocks. Reuters reported that Merck & Co., ...
In a statement sent to PREMIUM TIMES on Friday, CEPI said the project is designed to address long-standing challenges around the cost, supply and deployment of the vaccine, particularly in ...
Science Africa on MSN
US$ 30M for more affordable Ebola vaccines
By Sharon AtienoA partnership between the Coalition for Epidemic Preparedness Innovations (CEPI) and Merck (MSD) is set to ...
Merck's affordable Ebola vaccine initiatives, Abbott's profit challenges, U.S. vaccination policy changes under Health ...
SK Bioscience has joined a new international effort to advance an updated Zaire ebolavirus vaccine, following a funding agreement between the CEPI and Merck & Co.
CEPI to provide up to USD 30 million to support development of MSD's Zaire ebolavirus vaccineCollaboration addresses ...
SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results